Rapid Biomedical Insight Discovery with AI

Pharma R&D is increasingly costly and the industry is looking to AI for productivity and ROI improvements. A critical bottleneck in early stage R&D is insight discovery. Huge amounts of researcher time is spent interrogating the literature to find biological connections and uncover new insights, Elsevier has a history of deploying AI to transform these tasks. Guy and Ivana will take you through recent innovations in this space as well as some of the key lessons we have learned.